Top 20 Most Influential Oncology Professors

If you’re seeking expert cancer adivce, or if you want to study under the best oncology professors, you might look at universities that also maintain a cancer medical center. This is where you may find instructors who are versed in teaching as well as in research, clinical trials and groundbreaking discoveries. The following top 20 most influential oncology professors mostly come from those environments, but other influential professors can be found working in the community, too.

The following list is arranged alphabetically by surname.

  1. Dr. AbrahmDr. Janet L. Abrahm is an associate professor at Harvard Medical School and the Division Chief of Adult Palliative Care in the Department of Psychosocial Oncology and Palliative Care at the Dana Farber Cancer Institute and the Brigham and Women’s Hospital. Dr. Abrahm has over 100 publications, 75 percent of which are in the area of palliative care. She also helped develop and operationalize the Intensive Palliative Care Unit at Brigham and Women’s Hospital.
  2. Dr. Adams-CampbellDr. Lucile Adams-Campbell joined Georgetown University, Lombardi Comprehensive Cancer Center in 2008 as Professor of Oncology and Associate Director for Minority Health and Health Disparities Research. Dr. Adams-Campbell, former director of the Howard University Cancer Center, is an internationally recognized expert on health disparities. In 2008, she was elected to the prestigious Institute of Medicine.
  3. Dr. BuckmanDr. Robert Buckman is a medical oncologist at the Princess Margaret Hospital and professor in the Department of Medicine at the University of Toronto. He designed and teaches an undergraduate course in “breaking bad news,” which was given the UT Aikins Teaching Award in 1989. In 2003 he received the Fleming medal of the Royal Canadian Institute for the Advancement of Science. He is an adjunct professor at the M. D. Anderson Cancer Center, University of Texas.
  4. Dr. DavisDr. John Davis is an assistant professor of urology at the University of Texas M.D. Anderson Cancer Center, Houston Texas, where he holds director titles of the Urology Prostate Program, Prostate Ultrasound Services, and Prostate Cancer Screening. He has received an American Foundation of Urologic Disease Scholar award for proteomic applications in prostate cancer biomarkers. He has participated as an investigator in several clinical trials.
  5. Dr. DhodapkarDr. Madhav V. Dhodapkar is the Arthur H. and Isabel Bunker Professor of Medicine and professor of immunobiology, and Chief, Section of Hematology at the Yale School of Medicine. He also is director of hematologic malignancies, Yale Cancer Center. Dr. Dhodapkar’s clinical and research interests focus on the treatment of myeloma with a concentration on tumor-immune responses and development of novel biological therapies.
  6. Dr. EwaldDr. Andrew Ewald studies how cells build organs and how these same cellular processes can contribute to breast cancer metastasis at Johns Hopkins University School of Medicine. He will receive the American Association of Anatomists’ 2011 Morphological Sciences Award for his “outstanding contributions to the field of epithelial morphogenesis.” Ewald joined the Johns Hopkins faculty in 2008.
  7. Dr. GandaraDr. David Gandara, professor at the UC Davis Health System, is a leading expert in lung cancer and developmental therapeutics. Dr. Gandara is a recipient of the 1998 Oettinger Memorial Award for lung cancer research, and he has been named one of America’s best medical oncologists for lung cancer by Good Housekeeping magazine and one of America’s top doctors by the Connolly Guide. He also has broad expertise in developing new anti-cancer therapies.
  8. Dr. GospodarowiczDr. Mary Gospodarowicz is the Medical Director of the Cancer Program at Princess Margaret Hospital and University Health Network and the Regional Vice President of Cancer Care Ontario. She is also the professor and chair of the Department of Radiation Oncology at the University of Toronto and chief of the Radiation Medicine Program at Princess Margaret Hospital. This year she was appointed as President-Elect of UICC (Union for International Cancer Control).
  9. Dr. HahnDr. Stephen M. Hahn is chairman of the Department of Radiation Oncology, University of Pennsylvania. He was named the new Chair and Henry K. Pancoast Professor of Radiation Oncology at the School of Medicine in 2005. He also directs the Photodynamic Therapy Program and is co-program leader of Radiation Biology. Dr. Hahn has been a driving force in the clinical development of the hypoxia marker drug, EF5, for human use.
  10. Dr. Kieber-EmmonsDr. Thomas Kieber-Emmons holds the Jossetta Wilkins Chair in Breast Cancer Research and is Deputy Director of the Winthrop P. Rockefeller Cancer Institute. He is an acknowledged pioneer for his work on developing peptide mimetics of carbohydrate antigens as vaccines in both the cancer and pathogen areas. His group is focused on bringing the first structurally designed carbohydrate mimetic peptide into the clinic to prevent breast cancer recurrence in high-risk women.
  11. Dr. LambertDr. Paul Lambert, professor of oncology at the University of Wisconsin School of Medicine and Public Health, and was one of ten UW-Madison faculty members honored for their research with Kellett Mid-Career Awards. Lambert studies papillomaviruses that cause human cancer and recently identified a novel approach for treating and preventing these cancers. He is an editor of the journal Virology and director of the Cancer Biology graduate program.
  12. Sir David LaneProfessor Sir David Lane is Director of the Cancer Research UK Transformation Research Group at the University of Dundee, where he leads a research team studying human tumor suppressor gene function. He has published more than 290 research articles and is internationally recognized for his original discovery of the p53 protein SV40 T antigen complex and for his many subsequent contributions to the field. David Lane was knighted for his contribution to cancer research in January 2000.
  13. Riccardo LencioniProfessor Riccardo Lencioni is the Director of the Division of Diagnostic Imaging and Intervention in the Department of Hepatology and Liver Transplantation at Pisa University Hospital in Italy. He also is an Associate Professor of Radiology in the Faculty of Medicine of the University of Pisa. Professor Lencioni has received more than 40 international awards for his scientific contributions. He is a founder of the International Liver Cancer Association.
  14. Dr. LippmanScott M. Lippman, M.D. is chair of the Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX and professor, Department of Clinical Cancer Prevention, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX. Worldwide recognition for his work includes receiving the 2005 American Association for Cancer Research (AACR) Cancer Research and Prevention Foundation Award for Excellence in Cancer Prevention Research.
  15. Dr. MasoodDr. Shahla Masood currently holds the positions of professor and chair of the Department of Pathology at University of Florida College of Medicine–Jacksonville and chief of Pathology and Laboratory Medicine at Shands Jacksonville. She also directs pathology residency training, as well as cytopathology and breast pathology fellowship programs. She defined the cytomorphology of high-risk proliferative breast disease in early 1990s and pioneered the concept of cytomorphology as a breast cancer predictor.
  16. Prof. McKennaProfessor Gillies McKenna, director of Gray Institute for Radiation Oncology & Biology, University of Oxford, United Kingdom, is a world expert in radiotherapy research. In 2006, he was recruited to lead the Cancer Research UK-MRC Gray Institute for Radiation Oncology and Biology in Oxford. His research focuses on understanding the effect that radiation has on cells and how cancers can become resistant to radiotherapy. He was the 2005 recipient of the Association for Radiation Research Weiss Medal.
  17. Dr. PaiceDr. Judith Paice currently serves as the director of the Cancer Pain Program in the Division of Hematology-Oncology and a Research Professor of Medicine at Northwestern University’s Feinberg School of Medicine. She also is an RN, and she is using her experiences to chair the 6th Annual Pain and Palliative Care Conference in April 2011. Another passion is teaching pain and palliative care to healthcare professionals in developing countries.
  18. Dr. SartorDr. Carolyn I. Sartor is a radiation oncologist who, in her 10-plus years practicing radiation oncology at the University of North Carolina at Chapel Hill, led a number of clinical trials, both local and national, including avant-garde trials of intraoperative radiotherapy for early breast cancer and radiosensitization using novel biological therapies for advanced breast cancers. She became internationally known as one of the pre-eminent breast cancer physicians.
  19. Dr. Von RoennDr. Jamie H. Von Roenn is a Professor of Medicine at Northwestern University, Feinberg School of Medicine, in the Department of Medicine, Division of Hematology/Oncology. She is a full member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Co-Director of its Cancer Control Program. She is a frequent and sought after presenter on topics related to breast cancer and palliative medicine.
  20. Dr. WakeleeDr. Heather Wakelee is an Assistant Professor of Medicine in the Division of Oncology at Stanford University in California where she is the co-leader of the lung cancer disease management group. She is the principal investigator of the ongoing international lung cancer intergroup trial E1505 that is investigating the potential role of bevacizumab in addition to adjuvant chemotherapy for resected early stage non-small cell lung cancer.
This entry was posted in Oncology, Professors and tagged , , , , , , , , , . Bookmark the permalink.

Comments are closed.